PXL/HO/Cir-006/2020-21 Date: 11.04.2020
Hyderabad
Dear Sir/Madam,
Subject: Paracetamol Product Stock Position- Request for submission of details
Members are kindly aware, DGFT wide its Notification No.50/2015-20 dt:03.March 2020 restricted 13 API and its formulations and subsequently DGFT wide its Notification No.02/2015-20 dt 6th April 2020 lifted restriction on all the products except Paracetamol.
You are aware several representations have been made to DGFT for lifting the restrictions and also to expedite the product licenses in this context. Pharmexcil however has been receiving requests from several member companies requesting for lifting the export restriction on Paracetamol and also for expediting the product licenses by DGFT for export of Paracetamol.
In this context, we request member companies manufacturing the Paracetamol and its formulations to share the details in the format given below to enable Pharmexcil to take up the matter with DGFT on the impact and seek their help to lift the said restrictions on Paracetamol,
S.NO.
|
PRODUCT NAME & MANUFACTURED BY
|
D/MFG.
|
D/EXP.
|
PACKING
|
DGFT
Application No.
|
Country of Export
|
Supplies meant for Foreign Govt. or overseas company
|
|
PARACETAMOL
|
|
|
|
|
|
|
1.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Member companies are requested to submit the above details to rodelhi@pharmexcil.com with a copy to dgdesk@pharmexcil.com ASAP to enable Pharmexcil to re-present the matter with DGFT for their kind consideration.
With regards,
Uday Bhaskar
Director General
|